# K020325: L.a.M. Ipm Wound Gel

- Pathway: 510(k) (Traditional)
- Applicant: L.A.M. Pharmaceutical, Corp.
- Decided: Apr 15, 2002 after 74 days
- Product code: MGQ (Dressing, Wound And Burn, Hydrogel W/Drug And/Or Biologic)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K830708 (1983). 5 ancestors in all.
59 later devices descend from it; 4 cite it directly.
1 of 65 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K984413: Bionect Hydrogel, Fidia Pharmaceutical Corp. (1999) Summary page 1.
- K984388: HA Absorbent Wound Dressing, Convatec, A Division of E.R. Squibb & Sons (1999) Summary page 1.

## Most influential descendants
- K090725: Oculus Microcyn Wound Gel (2009), 56 descendants of its own
- K100918: Vashe Wound Therapy System Model: 9000-0014 (2010), 31 descendants of its own
- K123072: Vashe Wound Therapy Solution (2013), 25 descendants of its own
- K093585: Microcyn Skin and Wound Hydrogel (2010), 25 descendants of its own
- K093697: Vashe Wound Therapy Solution (2010), 20 descendants of its own

## Indications for use
Over-the-counter use of L.A.M. IPM Wound Gel is suitable for minor abrasions and minor cuts. Under the supervision of a healthcare professional, L.A.M. IPM Wound Gel is suitable for exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers, and for the management of mechanically or surgically debrided wounds.

Source page: https://510kreport.com/device/K020325
Methodology: https://510kreport.com/methodology